BYAKANGELICIN (b)
BYAKANGELICINa main furanocoumarin constituent isolated and characterized as an aldose reductase inhibitorand is effective for the treatment of sugar cataracts and diabetic neuropathy and hence might be useful as a lead compound for the development of new type drugs for clinical use.
Product Specifications
CAS Number
482-25-7
Purity
>98% (HPLC)
Solubility
In Vitro: DMSO : 50 mg/mL (149.56 mM)
Smiles
COc1c2ccoc2c (OC[C@@H] (O) C (C) (C) O) c2oc (=O) ccc12
Molecular Formula
C17H18O7
Molecular Weight
334.32
Storage Conditions
Storage temperature: -20°C. Stability: ≥ 2 years
Notes
For research use only.
Other Product Names
7H-Furo (32-g) (1) benzopyran-7-one 9- (23-dihydroxy-3-methylbutoxy) -4-methoxy- (R) -
Available Sizes
More Discoveries
Explore Other Products
Browse additional items from our catalog
K0736605 3x 1.0 µg
FAM90A21P sgRNA CRISPR/Cas9 All-in-One Lentivector set (Human)
Sign In for Pricing
View Details 
24104121 3x 1.0µg DNA
HV1S CRISPRa sgRNA lentivector (set of three targets)(Human)
Sign In for Pricing
View Details 126332-APC 100 µL
ENO2 (Gamma-enolase, 2-phospho-D-glycerate hydro-lyase, Enolase 2, Neural Enolase, Neuron-specific Enolase, NSE) (APC)
Sign In for Pricing
View Details